HDAC6 and melanoma: In addition, our data, knocking down individual HDAC proteins, argues that a highly specific HDAC6 inhibitor in melanoma cells is unlikely to effectively modulate the expression of PD-L1, PD-L2, MHCA or ODC in a manner like AR42 or valproate.